Osaka, Japan

Naoki Ishiguro


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2003-2004

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Naoki Ishiguro: Innovator in Pharmaceutical Chemistry

Introduction

Naoki Ishiguro is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patents. With a total of two patents to his name, Ishiguro's work focuses on developing new drug compositions and methods for treating various medical conditions.

Latest Patents

Ishiguro's latest patents include "2′-Halo-3′,5′-dialkoxyphen-1′-yl-imino-2-imidazolidine and the use thereof as a drug." This invention relates to a specific compound and its pharmacologically acceptable salts, which can be utilized in pharmaceutical compositions. His other patent, "Use of 2-amino-1-(4-hydroxy-2-methanesulfonamidophenyl)ethanol for treating urinary incontinence," outlines a method for treating urinary incontinence by administering an effective amount of the compound to patients in need.

Career Highlights

Throughout his career, Naoki Ishiguro has worked with notable companies in the pharmaceutical industry. He has been associated with Boehringer Ingelheim Pharma GmbH & Co. KG and Boehringer Ingelheim Pharma KG. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Ishiguro has collaborated with esteemed colleagues in his field, including Franz Esser and Pascale Pouzet. These collaborations have likely enhanced his research and development efforts, leading to his successful patent applications.

Conclusion

Naoki Ishiguro is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in drug development. His innovative patents and collaborations reflect his commitment to improving medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…